Central Chondrosarcoma, Grade 2 research hub

Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma

This study is testing a new medicine, Atezolizumab, for children and young people aged 2 to 17 with certain types of rare cancers: clear cell sarcoma or chondrosarcoma. It aims to see how well the medicine helps the body's immune system fight the cancer.